Nath Bio-Genes (India) cash flow

Latest FY26

Cash from operations: −₹12.6cr₹17.6 cr in FY25
Capital spending: ₹3.0cr−62.1% on FY25
Free cash flow: −₹15.6cr₹9.7 cr in FY25
Cash from financing: −₹3.8cr−₹2.1 cr in FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Changes in working capital
Adjustments to reconcile profit — non-cash items						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	—	4.0	3.8	3.3	−3.0
	—	0.0	0.0	9.1	0.0
	—	−1.8	1.0	0.0	0.0
	—	0.0	0.0	0.1	0.0
	—	0.2	−0.3	−0.0	0.0
	—	−0.0	−0.5	0.0	0.0
	—	−113	−108	−22.5	12.5
	—	−0.4	3.8	2.8	0.0
	—	0.0	0.0	0.0	11.9
	—	0.0	1.7	0.0	0.0
	—	25.6	0.0	−3.9	−0.4
	—	1.5	0.0	−1.1	−0.0
	—	51.6	36.2	15.6	−15.0
	—	0.0	−27.9	0.0	0.0
	—	−35.0	−2.5	0.0	0.3
	—	0.0	63.2	−0.3	25.8
	—	1.4	0.0	29.3	−20.8
	—	3.9	0.0	−3.4	0.0
	—	−6.0	0.5	−0.2	0.1
Cash from operating activities
	43.4	46.3	40.6	41.6	36.2
	—	−67.4	−28.8	28.5	11.4
	—	−21.1	11.8	70.0	47.6
	—	−6.5	−3.6	−0.3	0.0
	—	−16.0	−10.5	0.0	10.1
	—	0.0	0.0	0.9	0.0
	—	0.9	1.1	0.3	−0.9
	—	−12.6	17.6	70.3	38.4
Cash from investing activities
	—	3.0	7.9	8.4	2.5
	—	0.0	0.0	0.0	0.1
	—	0.0	0.1	0.0	0.0
	—	0.1	0.3	0.0	0.0
	—	0.1	0.0	1.0	0.0
	—	0.0	0.0	0.0	0.4
	—	0.0	0.0	18.4	0.0
	—	6.5	3.6	0.3	0.0
	—	3.5	−4.0	−27.4	−2.9
Cash from financing activities
	—	−4.3	13.4	−2.4	−0.3
	—	−10.1	1.2	−3.2	−13.4
	—	−16.0	10.5	9.1	10.1
	—	3.8	3.8	−3.8	3.8
	—	−21.8	−0.0	0.0	−0.9
	—	−3.8	−2.1	−4.5	−1.7
	—	−12.9	11.5	38.4	33.8
	—	−12.9	11.5	38.4	33.8
	—	—	—	76.4	38.0
Reference items
	49.3	52.4	49.8	49.9	48.7
	10.1%	11.8%	13.7%	15.0%	16.2%
	−15.6	−15.6	9.7	61.9	35.8
	—	−15.6	16.2	53.0	—
	−₹8.20	−₹8.20	₹5.08	₹32.57	₹18.85
	—	−0.30×	0.46×	1.77×	1.10×
	—	0.9	1.1	0.3	−0.9
	—	16.0	10.5	9.1	10.1

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

NATHBIOGEN₹131.40

Nath Bio-Genes (India) Limited

· FMCG & Retail

₹ CrorePeersSARVESHWAR INDOUS SUKHJITS KOHINOOR AGRITECH REGAAL BSHSL GULPOLYMcap ₹250 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation	-3.0	3.3	3.8	4.0	—
+ Finance Costs	0.0	9.1	0.0	0.0	—
+ Fair Value (Gains) / Losses	0.0	0.0	1.0	-1.8	—
+ Undistributed Profits of Associates	0.0	0.1	0.0	0.0	—
+ Other Non-cash Items	0.0	-0.0	-0.3	0.2	—
+ Other Reconciling Items	0.0	0.0	-0.5	-0.0	—
Changes in Working Capital
+ Inventories	12.5	-22.5	-107.7	-112.5	—
+ Trade Receivables — Current	0.0	2.8	3.8	-0.4	—
+ Trade Receivables — Non-current	11.9	0.0	0.0	0.0	—
+ Other Financial Assets — Non-current	0.0	0.0	1.7	0.0	—
+ Other Current Assets	-0.4	-3.9	0.0	25.6	—
+ Other Non-current Assets	-0.0	-1.1	0.0	1.5	—
+ Trade Payables — Current	-15.0	15.6	36.2	51.6	—
+ Other Financial Liabilities — Current	0.0	0.0	-27.9	0.0	—
+ Other Financial Liabilities — Non-current	0.3	0.0	-2.5	-35.0	—
+ Other Current Liabilities	25.8	-0.3	63.2	0.0	—
+ Other Non-current Liabilities	-20.8	29.3	0.0	1.4	—
+ Provisions — Current	0.0	-3.4	0.0	3.9	—
+ Provisions — Non-current	0.1	-0.2	0.5	-6.0	—
Cash from Operating Activities
Profit Before Tax (per I/S)	36.2	41.6	40.6	46.3	43.4
+ Total Adjustments (incl. Working Capital)	11.4	28.5	-28.8	-67.4	—
Cash from Operations (pre-tax)	47.6	70.0	11.8	-21.1	—
+ Interest Received — Operating	0.0	-0.3	-3.6	-6.5	—
+ Interest Paid — Operating	10.1	0.0	-10.5	-16.0	—
+ Other Inflows / (Outflows) — Operating	0.0	0.9	0.0	0.0	—
+ Income Taxes Paid	-0.9	0.3	1.1	0.9	—
Cash from Operating Activities	38.4	70.3	17.6	-12.6	—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)	2.5	8.4	7.9	3.0	—
+ Acq of Intangible Assets	0.1	0.0	0.0	0.0	—
+ Disp of Fixed Assets	0.0	0.0	0.1	0.0	—
+ Disp of Intangible Assets	0.0	0.0	0.3	0.1	—
+ Acq of Investment Property	0.0	1.0	0.0	0.1	—
+ Acq of Other Long-term Assets	0.4	0.0	0.0	0.0	—
+ Loans & Advances Made	0.0	18.4	0.0	0.0	—
+ Interest Received — Investing	0.0	0.3	3.6	6.5	—
Cash from Investing Activities	-2.9	-27.4	-4.0	3.5	—
Cash from Financing Activities
+ Proceeds from Borrowings	-0.3	-2.4	13.4	-4.3	—
+ Repayment of Borrowings	-13.4	-3.2	1.2	-10.1	—
+ Interest Paid	10.1	9.1	10.5	-16.0	—
+ Dividends Paid	3.8	-3.8	3.8	3.8	—
+ Other Inflows / (Outflows) — Financing	-0.9	0.0	-0.0	-21.8	—
Cash from Financing Activities	-1.7	-4.5	-2.1	-3.8	—
Net Changes in Cash (pre-FX)	33.8	38.4	11.5	-12.9	—
Net Changes in Cash	33.8	38.4	11.5	-12.9	—
Closing Cash	38.0	76.4	—	—	—
Reference Items
EBITDA	48.7	49.9	49.8	52.4	49.3
EBITDA Margin %	16.17	14.99	13.65	11.78	10.07
Free Cash Flow (CFO − Capex)	35.8	61.9	9.7	-15.6	-15.6
Free Cash Flow to Equity	—	53.0	16.2	-15.6	—
Free Cash Flow per Basic Share	18.85	32.57	5.08	-8.20	-8.20
Cash Flow to Net Income	1.10	1.77	0.46	-0.30	—
Cash Paid for Taxes	-0.9	0.3	1.1	0.9	—
Cash Paid for Interest	10.1	9.1	10.5	16.0	—

As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.